Simultaneous quantification of cilostazol and its primary metabolite 3,4-dehydrocilostazol in human plasma by rapid liquid chromatography/tandem mass spectrometry
Tóm tắt
Từ khóa
Tài liệu tham khảo
Akiyama H, Kudo S, Shimizu T (1985) Arznei-Forsch 35:1133–1140
Ramakrishna NVS, Koteshwara M, Vishwottam KN, Puran S, Manoj S, Santosh M (2004) J Pharm Biomed Anal 36:505–515
Ramakrishna NVS, Vishwottam KN, Puran S, Koteshwara M, Manoj S, Santosh M (2004) J Chromatogr B 809:117–124
Ramakrishna NVS, Vishwottam KN, Puran S, Koteshwara M, Manoj S, Santosh M (2004) J Chromatogr B 809:243–249
Ramakrishna NVS, Vishwottam KN, Puran S, Manoj S, Santosh M, Koteshwara M (2004) J Mass Spectrom 39:824–832
Ramakrishna NVS, Vishwottam KN, Puran S, Manoj S, Santosh M, Wishu S, Koteshwara M (2004) J Chromatogr B 805:13–20
Ramakrishna NVS, Vishwottam KN, Manoj S, Koteshwara M, Chidambara J, Varma DP (2005) Biomed Chromatogr 19:539–548
Ramakrishna NVS, Vishwottam KN, Puran S, Koteshwara M, Manoj S, Santosh M, Varma DP (2005) J Pharm Biomed Anal 39:1006–1013
Ramakrishna NVS, Vishwottam KN, Manoj S, Koteshwara M, Santosh M, Chidambara J, Ravi Kumar B (2005) Rapid Commun Mass Spectrom 19:1970–1978
Nirogi RVS, Kandikere VN, Shukla M, Mudigonda K, Maurya S, Boosi R, Yerramilli A (2005) Anal Chim Acta DOI 10.1016/j.aca.2005.08.007
US Department of Health and Human Services(2001) Guidance for industry: bioanalytical method validation. , Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD